Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03971838 · ClinicalTrials.gov registry record · NA
Diabetes Prevention Programming for Women With a History of Gestational Diabetes
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 117
- Enrollment target
NCT03971838: Completed NA study, sponsored by Indiana University.
NCT03971838 is a NA study that has completed, run by Indiana University. The registered enrollment target is 117 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03971838, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 117 participants
- Enrollment target
Study Summary
The purpose of this study is to offer women with a history of gestational diabetes access to diabetes prevention programming; their children 10 and older can participate.
Primary Outcome
Enrollment and participation rates in a diabetes prevention intervention
Interventions
- BEHAVIORAL Positive Outcomes for Women
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
What the finished NCT03971838 record still lists
NCT03971838 is an interventional study that assigns participants to a tested intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Positive Outcomes for Women is the first listed.
NCT03971838 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03971838 about?
NCT03971838 is a clinical study titled "Diabetes Prevention Programming for Women With a History of Gestational Diabetes". The purpose of this study is to offer women with a history of gestational diabetes access to diabetes prevention programming; their children 10 and older can participate.
What is the current status of trial NCT03971838?
This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 2019-06-01. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03971838?
The interventions under investigation include: Positive Outcomes for Women (BEHAVIORAL).
Who is sponsoring clinical trial NCT03971838?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03971838's enrollment target sits among peer trials
117 807th of 2000 higher than 1,193 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT04940585 · 117 participants · NA
ROSE in Sunset Park
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI